Patient Guide: A proof-of Concept Study to Assess Safety and Tolerability of HM15421/GC1134A in Patients With Fabry Disease

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 10 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT06858397
Status: 🟢 Enrolling Now
Condition: Fabry Disesase
Phase: PHASE1, PHASE2

Where You Can Participate

This study is available at 10 locations across the country.

Top locations include:
  • • Los Angeles, California
  • • Kansas City, Kansas
  • • Minneapolis, Minnesota
  • • And 7 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A proof-of Concept Study to Assess Safety and Tolerability of HM15421/GC1134A in Patients With Fabry Disease - Join Clinical Trial NCTNCT06858397

How to Join This Clinical Trial - NCTNCT06858397

Learn how to participate in this PHASE1, PHASE2 trial studying an investigational therapy for Fabry Disesase. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Fabry Disesase. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Fabry Disesase
Treatment Being Tested
Investigational treatment
Study Phase
PHASE1, PHASE2 - Safety and effectiveness study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT06858397 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 10 locations. Find a study site near you:

Clinical Research Site

Los Angeles, California 90095 - United States

Status: RECRUITING

Clinical Research Site

Kansas City, Kansas 66160-8500 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Minneapolis, Minnesota 55455 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Cincinnati, Ohio 45229-3039 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Pittsburgh, Pennsylvania 15224 - United States

Status: RECRUITING

Clinical Research Site

Fairfax, Virginia 22030 - United States

Status: RECRUITING

Clinical Research Site

Rosario, Santa Fe S2000 - Argentina

Status: NOT_YET_RECRUITING

Clinical Research Site

Ciudad Autónoma de Buenos Aires, C1199ABB - Argentina

Status: RECRUITING

Clinical Research Site

Yangsan, Gyeongsangnam-do 50612 - Korea, Republic of

Status: RECRUITING

Clinical Research Site

Seoul-si, 03722 - Korea, Republic of

Status: RECRUITING

How to Enroll in This Study

To learn more about participating in this PHASE1, PHASE2 clinical trial for Fabry Disesase:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships